CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-23 | ADAMIS ANTHONY P Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-06-23 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2022-03-14 | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Purchase | +1,000 | $12.21 | $12K | 1,000 |
| 2022-02-28 | Jones David Scott SVP & Chief Commercial Officer | Option exercise | +4,105 | 16,729 | ||
| 2022-02-28 | Jones David Scott SVP & Chief Commercial Officer | Shares withheld for taxes | −1,130 | $9.95 | $11K | 15,599 |
| 2022-02-28 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Restricted Stock Units | −4,105 | 0 | ||
| 2022-02-28 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +4,105 | 19,945 | ||
| 2022-02-28 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −1,294 | $9.95 | $13K | 18,651 |
| 2022-02-28 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −4,105 | 0 | ||
| 2022-02-28 | Lurker Nancy President & CEO | Option exercise | +12,466 | 150,281 | ||
| 2022-02-28 | Lurker Nancy President & CEO | Option exercise · Restricted Stock Units | −12,466 | 0 | ||
| 2022-02-21 | Lurker Nancy President & CEO | Option exercise | +13,717 | 137,815 | ||
| 2022-02-21 | Lurker Nancy President & CEO | Option exercise · Restricted Stock Units | −13,717 | 13,718 | ||
| 2022-02-09 | Landis John B. Director | Option exercise | +2,500 | 8,400 | ||
| 2022-02-09 | Landis John B. Director | Option exercise · Restricted Stock Units | −2,500 | 0 | ||
| 2022-02-09 | Landis John B. Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 | ||
| 2022-02-09 | Landis John B. Director | Grant or award · Stock Option (Right to Buy) | +11,000 | 11,000 | ||
| 2022-02-09 | GUYER DAVID R Director | Option exercise | +2,500 | 4,400 | ||
| 2022-02-09 | GUYER DAVID R Director | Option exercise · Restricted Stock Units | −2,500 | 0 | ||
| 2022-02-09 | GUYER DAVID R Director | Grant or award · Restricted Stock Units | +3,000 | 3,000 |
Page 27 of 31 · 616 trades